Annual report pursuant to Section 13 and 15(d)

PRIOR PERIOD RESTATEMENT (Tables)

v3.6.0.2
PRIOR PERIOD RESTATEMENT (Tables)
 12 Months Ended
Nov. 30, 2016
Condensed Financial Statements [Table Text Block]
    Year ended     Quarter ended     Quarter ended     Quarter ended     Year ended  
    November 30, 2014     February 28, 2015     May 31, 2015     August 31, 2015     November 30, 2015  
                                                             
    Prior to           Prior to           Prior to           Prior to           Prior to        
    Restatement     Restated     Restatement     Restated     Restatement     Restated     Restatement     Restated     Restatement     Restated  
    $       $     $       $     $      $       $      $     $       $  

Consolidated Balance Sheet:

                                                           

 

                                                            

Deferred financing costs

   170,674     165,230     155,000     137,301     138,978     123,770     122,959     103,510     107,108     88,970  

Total Assets

   1,557,052     1,551,608     1,011,348     993,649     3,056,766     3,041,558     2,545,867     2,526,418     2,166,418     2,148,280  

Convertible Debentures

   1,398,592     1,353,981     1,398,592     1,238,890     1,398,592     1,245,551     1,398,592     1,177,395     1,398,592     1,161,750  

Total Liabilities

   1,559,997     1,515,386     1,514,011     1,354,309     1,524,026     1,370,985     1,459,190     1,237,993     1,571,921     1,335,079  

Accumulated deficit

   (24,042,769 )   (24,003,602 )   (24,531,262 )   (24,389,259 )   (25,000,244 )   (24,862,410 )   (25,467,782 )   (25,266,031 )   (26,593,207 )   (26,374,503 )

 

                                                            

Consolidated Statement of operations and Comprehensive loss:

                                                           

 

                                                            

Foreign currency translation (gain) loss

   -     (39,167 )   -     (102,836 )   -     4,169     -     (63,917 )   -     (179,537 )

Total Operating Expenses

   2,670,074     2,630,907     433,120     330,284     424,010     428,179     414,490     350,573     2,354,105     2,174,568  

Loss from Operations

   (2,654,917 )   (2,615,750 )   (431,436 )   (328,600 )   (410,657 )   (414,826 )   (409,213 )   (345,296 )   (2,319,040 )   (2,139,503 )

Loss before Income Taxes

   (2,722,412 )   (2,683,245 )   (488,493 )   (385,657 )   (468,982 )   (473,151 )   (467,538 )   (403,621 )   (2,550,438 )   (2,370,901 )

Net Loss

   (2,722,412 )   (2,683,245 )   (488,493 )   (385,657 )   (468,982 )   (473,151 )   (467,538 )   (403,621 )   (2,550,438 )   (2,370,901 )

Comprehensive Loss

   (2,754,118 )   (2,714,951 )   (499,718 )   (396,882 )   (464,597 )   (468,766 )   (469,833 )   (405,916 )   (2,565,471 )   (2,385,934 )

Loss per share - basic and diluted

   (0.06 )   (0.06 )   (0.01 )   (0.01 )   (0.01 )   (0.01 )   (0.01 )   (0.01 )   (0.05 )   (0.05 )

 

                                                            

 

                                                            

Consolidated Statement of Cash Flows

                                                           

 

                                                            

Net Loss

   (2,722,412 )   (2,683,245 )   (488,493 )   (385,657 )   (957,475 )   (858,808 )   (1,425,013 )   (1,262,429 )   (2,550,438 )   (2,370,901 )

Adjustment for: Foreign currency translation (gain) loss

         (39,167 )         (102,836 )         (98,667 )         (162,584 )         (179,537 )
Net cash used in operating activities   (1,940,050 )   (1,940,050 )   (507,246 )   (507,246 )   (908,650 )   (908,650 )   (1,417,684 )   (1,417,684 )   (1,738,824 )   (1,738,824 )